Results

1–4 of 4 results for David R. Chow

Baseline Characteristics of Patients Maintaining q12 and q16 Dosing With Aflibercept 8 mg vs Patients With Shortened Treatment Intervals Phase 3 PULSAR Post Hoc Analysis
David R. Chow, MD, FRCS(C)
Annual Meeting Talks
2023
New Instrumentation for VR Surgery
David R. Chow, MD, FRCS(C)
Updates from the Field
2019
What Are the Keys to Maximizing Visual Performance on a 3D Digital Assisted Vitrectomy System?
David R. Chow, MD, FRCS(C)
Annual Meeting Talks
2019
Advances in Endoillumination
David R. Chow, MD, FRCS(C)
Updates from the Field
2017